HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1171909Generated: October 25, 2026
Bromide ion → (S)-2-(2-benzyl-4-(3-(cyclopentyloxy)-4-methoxyphenyl)piperazin-1-yl)acetamide
https://huagongshe.com/reaction/1171909
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Bromide ion | HCID 259 | — |
| Reactant | 2-Bromoacetamide | HCID 69632 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | (S)-3-Benzyl-1-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazine | HCID 16725642 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | (S)-2-(2-benzyl-4-(3-(cyclopentyloxy)-4-methoxyphenyl)piperazin-1-yl)acetamide | HCID 23627744 | — |
Reaction Steps
A solution of the bishydrochloride salt of (S)-3-Benzyl-1-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazine (Example 2) (110 mg, 0.25 mmol) in THF (2 mL) at room temperature was treated with diisopropylethylamine (165 μL, 1.0 mmol) followed by 2-bromoacetamide (42 mg, 0.3 mmol). The reaction mixture was heated at 50° C. for 8 h and an additional amount of bromide (42 mg, 0.3 mmol) then added. The reaction mixture was then stirred for an additional 16 h at room temperature and evaporated. The crude reaction was then partitioned between EtOAc (3 mL) and a saturated aqueous NaHCO3 solution (3 mL). The organic phase was isolated and further washed with an additional portion of a saturated aqueous NaHCO3 solution (3 mL) and brine (2×3 mL).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07829713B2 |
|---|
| Source dataset | uspto-grants-2010_11 |
|---|
| ORD ID | ord-0b82a7b66e454e84ad26c5a1854d51e6 |
|---|
| Source note | uspto-grants-2010_11 |
|---|